Lipids in Health and Disease-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2024-04-20 ms4000000703438463 来自浙江省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：血脂与高脂血症胰腺炎
经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof

3 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-11-16 ms1000000749730642 来自湖南省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。

21 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2024-04-16 隔壁李叔叔来自浙江省

巨慢务必，3月24日通过technical checks，至今没有进展。

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-10-01 12313118m89暂无昵称来自江苏省

偏重的研究方向：血脂
经验分享：请问让带着修改意见重投是不是有希望接收？

122 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-12-05 白衣13 来自山西省

12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！

40 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2024-02-16 ms8000001080294008 来自河北省

偏重的研究方向：肥胖
经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-12-21 m1867679976 来自江西省

偏重的研究方向：流行病学;血脂的临床和基础研究
经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗

59 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-03-27 沁沁沁1987 来自四川省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肥胖;基础
经验分享：审稿道最后接受大概3个月左右

55 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2022-03-17 ms7000001749812875

审稿速度:2.0
偏重的研究方向：血脂异常
经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！

164 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199437, encodeId=b996219943eef, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：血脂与高脂血症胰腺炎 经验分享：2023.12月投的时候还是三区，2024.2大修的时候就2区了！经历过一次大修一次小修后成功接收，相对困难的就是10%以下的查重，并且只能在ithenticate上查重，接收2天后就收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58e38603135, createdName=ms4000000703438463, createdTime=Sat Apr 20 11:41:59 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2168804, encodeId=a3fc2168804c2, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问接收以后多久收到校对和交版面费的邮件呀？我的接收8天了还没收到下一步邮件😭。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13cb8849261, createdName=ms1000000749730642, createdTime=Thu Nov 16 12:18:25 CST 2023, time=2023-11-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2198760, encodeId=8a692198e6044, content=巨慢务必，3月24日通过technical checks，至今没有进展。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Tue Apr 16 10:39:21 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2160544, encodeId=491f21605447f, content=偏重的研究方向：血脂 经验分享：请问让带着修改意见重投是不是有希望接收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7cb2381156, createdName=12313118m89暂无昵称, createdTime=Sun Oct 01 16:49:47 CST 2023, time=2023-10-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172948, encodeId=e0a621e29487e, content=12.1投稿，12.4外审，接心软审稿人，让我中一篇吧，审稿人圣诞节快乐！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Tue Dec 05 01:02:06 CST 2023, time=2023-12-05, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2187639, encodeId=7af9218e63998, content=偏重的研究方向：肥胖 经验分享：请好心人解答一下，投稿后一直显示15 reviewers invited ,是还没有审稿人接受邀请吗？如果有人接受后，动态是否会更新呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a36414438, createdName=ms8000001080294008, createdTime=Fri Feb 16 12:35:47 CST 2024, time=2024-02-16, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2176354, encodeId=c7c721e635433, content=偏重的研究方向：流行病学;血脂的临床和基础研究 经验分享：谁知道我刚刚投了就要我去润色和查重，这还不一定接受，这还没开始就要花一大波钱，大家都是这样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=m1867679976, createdTime=Thu Dec 21 18:17:17 CST 2023, time=2023-12-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2122051, encodeId=81f021220512e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肥胖;基础 经验分享：审稿道最后接受大概3个月左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2RxfZB3ADmlD8FhRdTicfEfgJGnB8VLzbsUFVRW28nah136zBPvUESe92nVU11fACAI3OzhXlbUr6Eqs7IDYmkA/132, createdBy=70422376821, createdName=沁沁沁1987, createdTime=Mon Mar 27 13:00:59 CST 2023, time=2023-03-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203575, encodeId=87f812035e551, content=审稿速度:2.0 偏重的研究方向：血脂异常 经验分享：我来还愿了！这个杂志真的好快！快到我怀疑自己！2022.2.6提交，2.7外审，2.21大修，3.7返修回去，3.10再次大修；3.13返修回去，3.14返回来让改格式第三次修改，3.16返修回去之后，3.17接收！朋友们加油鸭！祝大家都顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75255581384, createdName=ms7000001749812875, createdTime=Thu Mar 17 20:23:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111496, encodeId=a3b22111496ac, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：血脂 经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。 我是别的期刊转投。它拒稿了。理由是查重没通过。 我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。 文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Jan 26 11:34:56 CST 2023, time=2023-01-26, status=1, ipAttribution=湖南省)]

2023-01-26 bigOne 来自湖南省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：血脂
经验分享：Lipids in Health and Disease是一个极其垃圾的杂志。
我是别的期刊转投。它拒稿了。理由是查重没通过。
我后来自己查了一下，最高的单篇居然8%，你猜猜是啥 The first similarity (311 words — 8%) is calculated from the fragments in the text similar with the whole www.ncbi.nlm.nih.gov internet.居然拿我这文章里类似 P<0.05 and 95% CI的文字碎片去匹配整个www.ncbi.nlm.nih.gov，得出单篇重复率超过8%。
文章都是自己写的，AJE润色了，给我整查重退稿。说实话，编辑稍微看看也知道这查重有问题。申诉了也没用。

52 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务